Ductal carcinoma in situ - update on risk assessment and management.

Ductal carcinoma in situ - update on risk assessment and management.

Item
http://www.wikidata.org/entity/Q38696796
Importance of cost-effectiveness and value in cancer care and healthcare policyBreast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?Implementation of shared decision-making in oncology: development and pilot study of a nurse-led decision-coaching programme for women with ductal carcinoma in situ.Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.The Baader-Meinhof phenomenon in ductal carcinoma in situ of the breast.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in IReply to the Baader-Meinhof phenomenon in ductal carcinomain situof the breastAtypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.
P2860

Ductal carcinoma in situ - update on risk assessment and management.

Item
http://www.wikidata.org/entity/Q38696796
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Ductal carcinoma in situ - update on risk assessment and management.
@en
type
label
Ductal carcinoma in situ - update on risk assessment and management.
@en
prefLabel
Ductal carcinoma in situ - update on risk assessment and management.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Ductal carcinoma in situ - update on risk assessment and management.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698